Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 2.2021, NCCN Clinical Practice Guidelines in OncologyMary B. Daly, Mary A. Dwyer, Michael Goggins et al.|Journal of the National Comprehensive Cancer Network|2021Cited by 1.1k
NCCN Guidelines Insights: Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 1.2020Mary B. Daly, Susan Darlow, Robert Pilarski et al.|Journal of the National Comprehensive Cancer Network|2020Cited by 507
NCCN Guidelines® Insights: Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 2.2024Mary B. Daly, Susan Darlow, Tuya Pal et al.|Journal of the National Comprehensive Cancer Network|2023Cited by 284
Recruitment, Genetic Counseling, and <i>BRCA</i> Testing for Underserved Women at a Public HospitalRobin Lee, John L. Ziegler, Mary Beattie et al.|Genetic Testing|2005Cited by 39